Use of bioluminescent aequorin for the pharmacological characterization of 5HT receptors

Journal of Receptor and Signal Transduction Research

Volumn 19, Issue 6, 1999, Pages 927-938

  Schaeffer, M T ^a   Cully, D ^a   Chou, M ^a   Liu, J ^a   Van Der Ploeg, L H T ^a   Fong, T M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEQUORIN; INOSITOL PHOSPHATE; KETANSERIN; MESULERGINE; MIANSERIN; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C AGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR;

ARTICLE; BIOLUMINESCENCE; CALCIUM CELL LEVEL; CELL LINE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EMBRYO; HUMAN; HUMAN CELL; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

EID: 0032867343     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899909038432     Document Type: Article

References (26)

1. Fisher, S. K. Homogegous and heterogenous regulation of receptor-stimulated phosphoinositide hydrolysis, Eur. J. Pharmacol. 288, 231-250, 1995.
2. Tsien, R. Y. Fluorescence measurement and photochemical manipulation of cytosolic free calcium, Trends in Neurosci. 10, 419-424, 1988.
3. Huang, R. R. C.; Yu, H.; Strader, C. D., and Fong, T. M. Localization of the ligand binding site of the neurokinin-1 receptor: interpretation of chimeric mutants and single residue substitutions, Mol. Pharmacol. 45, 690-695, 1994.
4. Garland, A. M.; Grady, E. F.; Lovett, M.; Vigna, S. R.; Frucht, M. M.; Krause, J. E., and Bunnett, N. W. Mechanism of desensitization and resensitization of G protein-coupled neurokinin-1 and neurokinin-2 receptors, Mol. Pharmacol. 49, 438-446, 1996.
5. Button, D., and Brownstein, M. Aequorin-expressing mammalian cell lines used to report calcium mobilization, Cell Calcium 14, 663-671, 1993.
6. Sheu, Y.-A.; Kricka, L. J., and Pritchett, D. B. Measurement of intracellular calcium using bioluminescent aequorin expressed in human cells, Anal. Biochem. 209, 343-347, 1993.
7. Kendall, J. M., and Badminton, M. N. Aequoria victoria bioluminescence moves into an exciting new era, Trends in Biotechnology 16, 216-224, 1998.
8. Boie, Y.; Stocco, R.; Sawyer, N.; Slipetz, D. M.; Ungrin, M. D.; Neuschafer-Rube, F.; Puschel, G.; Metters, K. M., and Abramovitz, M. Molecular characterization of the four rat prostaglandin E2 prostanoid receptor subtypes, Eur. J. Pharmacol. 340, 227-241, 1997.
9. McNamee, M. G. Isolation and characterization of cell membranes, BioTechniques 7, 466-475, 1989.
10. Huang, R. R. C.; Yu, H.; Strader, C. D., and Fong, T. M. Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor, Biochemistry 33, 3007-3013, 1994.
11. Bos, M.; Jenck, F.; Martin, J. R.; Moreau, J.-L.; Sleight, A. J.; Wichmann, J., and Widmer, U. Novel agonists of 5HT2c receptors, J. Med. Chem. 40, 2762-2769, 1997.
12. Berg, K. A.; Clarke, W. P.; Sailstad, C.; Saltzman, A., and Maayani, S. Signal transduction differences between 5HT type 2a and type 2c receptor systems, Mol. Pharmacol. 46, 477-484, 1994.
13. Choudhary, M. S.; Craigo, S., and Roth, B. L. A single point mutation (F340L) of a conserved phenylalanine abolishes DOI and mesulergine but not ketanserin binding to 5HT2 receptor, Mol. Pharmacol. 43, 755-761, 1993.
14. Sealfon, S. C.; Chi, L.; Ebersole, B. J.; Rodie, V.; Zhang, D.; Ballesteros, J. A., and Weinstein, H. Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5-HT2A receptor, J. Biol. Chem. 270, 16683-16688, 1995.
15. Hoyer, D.; Engel, G., and Kalkman, H. O. Molecular pharmacology of 5HT1 and 5HT2 recognition sites in rat and pig brain membranes, Eur. J. Pharmacol. 118, 13-23, 1985.
16. Leonhardt, S.; Gorospe, E., and Teitler, M. Molecular pharmacological differences in the interaction of serotonin with 5HT1c and 5HT2 receptors, Mol. Pharmacol. 42, 328-335, 1992.
17. Nelson, D. L. The serotonin-2 subfamily of receptors: pharmacological challenges, Med. Chem. Res. 3, 306-316, 1993.
18. Samama, P.; Cotecchia, S.; Costa, T., and Lefkowitz, R. J. A mutation-induced activated state of the beta2-adrenergic receptor, J. Biol. Chem. 268, 4625-4636, 1993.
19. Whaley, B. S.; Yuan, N.; Birnbaumer, L.; Clarke, R. B., and Barber, R. Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation, Mol. Pharmacol. 45, 481-489, 1994.
20. De Courcelles, D. d. C.; Leysen, J. E.; De Clerck, F.; Van Belle, H., and Janssen, P. A. J. Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-2 receptor sites, J. Biol. Chem. 260, 7603-7608, 1985.
21. Clancy, B. M., and Maayani, S. 5HT receptor is isolated rabbit aorta: characterization with tryptamine analogs, J. Pharmacol. Exp. Ther. 233, 761-769, 1985.
22. Hoyer, D.; Clarke, D. E.; Fozard, J. R.; Hartig, P. R.; Martin, G. R.; Mylechrane, E. J.; Saxena, P. R., and Humphrey, P. P. A. International union of pharmacology classification of receptors for 5HT, Pharmacol. Rev. 46, 157-203, 1994.
23. Johnson, M. P.; Mathis, C. A.; Shulgin, A. T.; Hoffman, A. J., and Nichols, D. E. [1125]-2-(2,5-dimethoxy-4-iodophenyl)aminoethane as a label for the 5HT2 receptor in rat frontal cortex, Pharmacol Biochem Behav 35, 211-217, 1990.
24. Darmani, N. A.; Martin, B. R.; Pandey, U., and Glennon, R. A. Do functional relationships exist between 5HT1a and 5HT2 receptors, Pharmacol Biochem Behav 36, 901-906, 1990.
25. Lubbert, H.; Snutch, T. P.; Dascal, N.; Lester, H. A., and Davidson, N. Rat brain 5HT1c receptors are encoded by a 5-6 kb mRNA size class and are functionally expressed in injected Xenopus oocytes, J. Neurosci. 7, 1159-1165, 1987.
26. Singer, A.; Boton, R.; Moran, O., and Dascal, N. Short-and long-term desensitization of serotonergic response in Xenopus oocytes injected with brain RNA, Pflugers Arch 416, 7-16, 1990.